Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes

Advances in Renal Replacement Therapy

Volumn 8, Issue 1, 2001, Pages 42-56

  Charra, Bernard ^a,b   VoVan, Cyrile ^a,b   Marcelli, Daniele ^a,b   Ruffet, Martial ^a,b   Jean, Guillaume ^a,b   Hurot, Jean Marc ^a,b   Terrat, Jean Claude ^a,b   Vanel, Thierry ^a,b   Chazot, Charles ^a,b  

^a Centre de Rein Artificiel de Tassin   (France)

^b Fresenius Medical Care AG   (Germany)

Author keywords

Diabetes mellitus; End stage renal failure; Epidemiology; Hemodialysis; Morbidity; Mortality

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIALYSIS; DISEASE DURATION; FRANCE; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PRIORITY JOURNAL;

EID: 0035128354     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2001.21708     Document Type: Article

References (58)

1. Variation and trends in incidence of childhood diabetes in Europe
2. Worldwide increase in incidence of type 1 diabetes - The analysis of the data on published incidence trends
3. Status of national diabetes programmes on the Americas
4. Diabetes in the next century: Challenges and opportunities
5. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes
6. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus
7. Similar risks of nephropathy in patients with type I or type II diabetes mellitus
8. Nephropathy in patients with type 2 diabetes mellitus
9. Declining incidence of nephropathy in insulin-dependent diabetes mellitus
10. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe
11. Haemodialysis for French diabetic patients
12. Haemodialysis for French diabetic patients
13. Health policies and epidemiology of diabetes among dialysed patients in France
14. Survival comparisons in haemodialysis between France and USA
15. 1983 to 1992: Report on regular dialysis and transplantation in Lombardy
16. The rising tide of endstage renal failure from diabetic nephropathy type II - An epidemiological analysis
17. Diabetic patients on renal replacement therapy: Analysis of Catalan Registry data. Renal Registry Committee
18. Les diabétiques traités en France pour insuffisance rénale chronique terminale. Enquête épidémiologique UREMIDIAB 2. Résultats préliminaires
19. Place du diabète dans l'épidémiologie de l'insuffisance rénale chronique
20. Glomerular involvement in type II diabetes - Is it all diabetic glomerulosclerosis?
21. The course of kidney function in type 2 (non insulin-dependent) diabetic patients with nephropathy
22. The impact of diabetes on patient's survival in dialysis patients with non-diabetic renal disease and in patients who develop diabetes during chronic dialysis
23. De novo diabetes in dialysis patients: When diabetes is not diabetic nephropathy
24. Survival as an index of adequacy of dialysis
25. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis
26. Second generation Logarithmic estimates of single-pool variable volume Kt/V: An analysis of error
27. Terminal chronic renal insufficiency in the south of Réunion. Epidemiology, survival on dialysis
28. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study
29. High impact of nephropathy on five-year mortality rates among patients with Type 2 diabetes mellitus from a multi-ethnic population in New Zealand
30. Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study)
31. Epidemiology, development and treatment of end-stage renal failure in type 2 (non insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories
32. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates
33. Patient characteristics at the start of ESRD: Data from the HCFA medical evidence form
34. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
35. Epidemiologic analysis of diabetic patients on chronic dialysis
36. Classification of diabetes in patients with end-stage renal disease
37. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
38. Prognosis of diabetic patients on dialysis: Analysis of Lombardy registry data
39. Nephropathy in type 2 diabetes - Epidemiological issues as viewed from Japan
40. Effect of intensive blood-glucose control with metformin on complications on overweight patients with type 2 diabetes (UKPDS 33)
41. The 6th report of Joint National Committee on detection, evaluation, and treatment of high blood pressure
42. Tight blood pressure control and risk of macrovascular and microvascular complicatios in type 2 diabetes: UKPDS 38
43. The Janus-faced aspect of "dry weight."
44. Hemodialysis in diabetics
45. Diabetic dialysis patients
46. Diabetic (DM) hemodialysis (HD) patients treated with high Kt/V have a lower risk of death than standard Kt/V
47. The effect of long, slow haemodialysis on patient survival
48. Predictors of mortality in long-term hemodialysis patients with a low prevalence of comorbid conditions
49. Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients
50. Survival and cardiovascular mortality in type I and type II diabetics with end stage renal disease
51. Long hemodialysis: The key to survival?
52. Hypertension, cardiovascular complications and survival in diabetic patients on maintenance haemodialysis
53. Abysmal prognosis of patients with type 2 diabetes entering dialysis
54. The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus